Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify
A Medicare pilot program offering discounted GLP-1 weight loss drugs is excluding some patients due to specific pre-existing conditions. Many patients, including those with severe health risks, are finding themselves ineligible for the $50 monthly price.
Why it matters
The exclusion criteria highlight gaps in healthcare access for high-risk patients seeking treatment for obesity-related conditions.
In January, Jeff La Marca got a prescription for the popular weight loss drug Zepbound. But he couldn't afford the $750 monthly price tag.
The article presents the issue from the perspective of affected patients while acknowledging the program's structure.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in